NEW YORK (GenomeWeb News) – Gene Logic this week named Charles Dimmler its new CEO. Dimmler replaces Mark Gessler, who will maintain his position as chairman of the board of directors.
 
Dimmler has been on Gene Logic’s board of directors for 10 years, and has involved in biotechnology management and finance for 20.

Affymetrix has named Robert Wayman to its board of directors.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.